20. November 2009 02:14
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced the United States Patent and Trademark Office has allowed multiple claims in one of the company’s recent patent applications. US patent application 12/005653, “Short Bioactive Peptides for Cellular and Immunological Modulation,” covers a number of peptides including Heptapeptide-7, a SmartPeptides™ technology and lead component in the Striking™ Skin Care line. The patent is expected to issue shortly.
[More]
19. November 2009 08:45
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI’s Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.
[More]
d505c6a1-f56f-4272-8a57-4c3df345aad8|0|.0
Posted in: Device / Technology News | Medical Condition News
Tags: Angioplasty, Atherosclerosis, Balloon Angioplasty, Calcium, Catheter, Dialysis, Hospital, Peripheral Arterial Disease, Stenosis, Stent, Ultrasound, Wound Healing
18. November 2009 03:49
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
[More]
17. November 2009 11:02
Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product’s safety and efficacy in the promotion of healing venous leg ulcers (VLUs). Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process.
[More]
17. November 2009 03:36
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
[More]
52d6ae04-8005-4377-aa8f-72b645331f28|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Abdominal Pain, Angiogenesis, Anthracycline, Antibody, Avastin, Back Pain, Bevacizumab, Biotechnology, Birth Control, Blood Pressure, Blood Vessel, Bone, Brain, Breast Cancer, Cancer, Capecitabine, Cell, Chemotherapy, Congestive Heart Failure, Dehydration, Dermatitis, Diarrhea, Docetaxel, Fertility, Fistula, Headache, Heart Failure, Low Blood Pressure, Nausea, Nervous System, Paclitaxel, Pregnancy, Stroke, VEGF, Vomiting, Wound Healing
16. November 2009 07:40
SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports its achievements and financial results for the three and nine months ended September 30, 2009.
[More]
1f1947f1-20f1-46fb-b97c-0a3bd82b41f5|0|.0
Posted in: Business / Finance
Tags: Bone, Cartilage, Hospital, Orthopedic, Plantar fasciitis, Plastic Surgery, Spine, Tendonitis, Tissue Engineering, Ulcer, Wound Healing
12. November 2009 03:07
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
[More]
922ef69d-cb26-41b9-aac6-199d5dca9bc3|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Anti-Inflammatory, Arthritis, Atherosclerosis, Cancer, Cell, Diabetes, Drug Delivery, Immunology, Macrophage, Rheumatoid Arthritis, Rhinitis, Wound Healing
11. November 2009 07:53
Research and Markets has announced the addition of the "Competitor Analysis: TGF-R Agonists and Antagonists" report to their offering.
[More]
11. November 2009 07:48
PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.
[More]
6. November 2009 23:36
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.
[More]
a2adf8f1-ad30-4800-bf56-2c2a04c02bae|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Blood Pressure, Blood Vessel, Cancer, Cell, Chemotherapy, Glaucoma, Gonorrhea, Hypoxia, Malaria, Pediatrics, Pharmacology, Tuberculosis, Virus, Wound Healing
4. November 2009 04:45
Marking a significant bench to bedside research milestone in Singapore, the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, and the National University Hospital (NUH) launched the IBN iCare and the NUH Eye Centre @ Biopolis at an official opening ceremony officiated by the Senior Minister of State for Trade and Industry and Education, S. Iswaran, at the Biopolis on Nov. 3, 2009.
[More]
cd40adbf-8526-430a-ad4d-be580c93d38d|1|5.0
Posted in: Medical Science News
Tags: Cancer, Cardiology, Cell, Contact Lens, Dentistry, Drug Delivery, Education, Gastroenterology, Glaucoma, Gynaecology, Hepatology, Hospital, Implants, Macular Degeneration, Myopia, Nanotechnology, Obstetrics, Occupational Health, Oncology, Ophthalmology, Quantum Dots, Stem Cell, Tissue Engineering, Trauma, Vision Impairment, Wound Healing
3. November 2009 00:10
Cardium Therapeutics today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate.
[More]
30. October 2009 06:14
Dr. H. Dwight Cavanagh, vice chairman of ophthalmology at UT Southwestern Medical Center, has been named the 2009 recipient of the prestigious Castroviejo Medal, one of the top ophthalmology prizes in the world.
[More]
30. October 2009 04:03
The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons.
[More]
29. October 2009 05:48
Prospera Technologies announced today that, at the Clinical Symposium on Advances in Skin & Wound Care in San Antonio, Texas, Oct 22-25, 2009, Malin Malmsjo MD., Ph.D. of Lund University in Lund, Sweden, presented significant new research comparing the differences and quality of granulation tissue in foam versus gauze based NPWT.
[More] 
Subscribe